$INMB 8-K SEC Filings

Filed On	Filing
21 Oct 2026	8-K: Regulation FD Disclosure; Other Events Two Late-Stage Platforms Targeting Inflammation- Driven Disease Corporate Presentation October 2026 NASDAQ: INMB
14 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events Appointments strengthen rare-disease commercialization planning and strategic partnering capabilities as Ebstrocel™ advances toward potential commercialization
31 Jul 2026	8-K: Other Events
01 Jul 2026	8-K: Entry into a Material Definitive Agreement
23 Jun 2026	8-K: Other Events
17 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
02 Jun 2026	8-K: Other Events
14 May 2026	8-K: Other Events
05 May 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
27 Feb 2026	8-K: Regulation FD Disclosure
23 Feb 2026	8-K: Other Events
19 Feb 2026	8-K: Other Events
13 Feb 2026	8-K: Regulation FD Disclosure
27 Jan 2026	8-K: Regulation FD Disclosure
23 Dec 2025	8-K: Entry into a Material Definitive Agreement
19 Dec 2025	8-K: Entry into a Material Definitive Agreement
10 Dec 2025	8-K: Termination of a Material Definitive Agreement
08 Dec 2025	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
05 Dec 2025	8-K: Other Events
03 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation

Comments